South Korea
# |
Name |
Price to Sales Ratio (P/S) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
622.22 |
Feb. 3, 2025 | USD 64.97 | -2.50% |
|
South Korea |
|
2 |
195.71 |
Feb. 3, 2025 | USD 240.05 | -5.25% |
|
South Korea |
|
3 |
189.85 |
Feb. 3, 2025 | USD 17.88 | -1.83% |
|
South Korea |
|
4 |
81.89 |
Feb. 3, 2025 | USD 1.65 | -4.10% |
|
South Korea |
|
5 |
55.23 |
Feb. 3, 2025 | USD 8.66 | -7.96% |
|
South Korea |
|
6 |
43.60 |
Feb. 3, 2025 | USD 3.04 | -3.81% |
|
South Korea |
|
7 |
33.33 |
Feb. 3, 2025 | USD 1.61 | -1.19% |
|
South Korea |
|
8 |
31.21 |
Feb. 3, 2025 | USD 11.83 | -21.52% |
|
South Korea |
|
9 |
25.96 |
Feb. 3, 2025 | USD 1.73 | -2.46% |
|
South Korea |
|
10 |
24.89 |
Feb. 3, 2025 | USD 25.27 | 1.91% |
|
South Korea |
|
11 |
22.20 |
Feb. 3, 2025 | USD 70.28 | -5.55% |
|
South Korea |
|
12 |
18.50 |
Feb. 3, 2025 | USD 745.69 | 1.15% |
|
South Korea |
|
13 |
17.26 |
Feb. 3, 2025 | USD 3.75 | -3.31% |
|
South Korea |
|
14 |
15.97 |
Feb. 3, 2025 | USD 119.86 | -2.20% |
|
South Korea |
|
15 |
15.59 |
Feb. 3, 2025 | USD 10.77 | -3.15% |
|
South Korea |
|
16 |
12.86 |
Feb. 3, 2025 | USD 1.97 | -3.64% |
|
South Korea |
|
17 |
12.84 |
Feb. 3, 2025 | USD 4.40 | -2.27% |
|
South Korea |
|
18 |
11.68 |
Feb. 3, 2025 | USD 7.21 | -0.62% |
|
South Korea |
|
19 |
10.58 |
Feb. 3, 2025 | USD 1.23 | -3.88% |
|
South Korea |
|
20 |
9.31 |
Feb. 3, 2025 | USD 32.21 | -3.61% |
|
South Korea |
|
21 |
8.15 |
Feb. 3, 2025 | USD 5.00 | -8.15% |
|
South Korea |
|
22 |
6.90 |
Feb. 3, 2025 | USD 15.36 | -2.10% |
|
South Korea |
|
23 |
5.66 |
Feb. 3, 2025 | USD 54.68 | -7.62% |
|
South Korea |
|
24 |
5.64 |
Feb. 3, 2025 | USD 8.83 | 4.03% |
|
South Korea |
|
25 |
5.44 |
Feb. 3, 2025 | USD 34.59 | -4.65% |
|
South Korea |
|
26 |
4.76 |
Feb. 3, 2025 | USD 83.97 | -5.00% |
|
South Korea |
|
27 |
3.88 |
Feb. 3, 2025 | USD 1.42 | -2.25% |
|
South Korea |
|
28 |
3.59 |
Feb. 3, 2025 | USD 4.14 | -7.03% |
|
South Korea |
|
29 |
3.24 |
Feb. 3, 2025 | USD 77.77 | -3.69% |
|
South Korea |
|
30 |
2.75 |
Feb. 3, 2025 | USD 15.77 | -2.26% |
|
South Korea |
|
31 |
2.66 |
Feb. 3, 2025 | USD 0.29 | -4.87% |
|
South Korea |
|
32 |
2.65 |
Feb. 3, 2025 | USD 1.89 | -1.74% |
|
South Korea |
|
33 |
2.47 |
Feb. 3, 2025 | USD 1.18 | -3.42% |
|
South Korea |
|
34 |
2.42 |
Feb. 3, 2025 | USD 11.00 | -3.03% |
|
South Korea |
|
35 |
2.36 |
Feb. 3, 2025 | USD 0.97 | -2.69% |
|
South Korea |
|
36 |
2.33 |
Feb. 3, 2025 | USD 3.10 | -3.13% |
|
South Korea |
|
37 |
2.28 |
Feb. 3, 2025 | USD 6.88 | -1.99% |
|
South Korea |
|
38 |
1.92 |
Feb. 3, 2025 | USD 8.02 | 4.65% |
|
South Korea |
|
39 |
1.88 |
Feb. 3, 2025 | USD 159.35 | -4.24% |
|
South Korea |
|
40 |
1.66 |
Feb. 3, 2025 | USD 11.53 | -7.22% |
|
South Korea |
|
41 |
1.61 |
Feb. 3, 2025 | USD 16.51 | 0.47% |
|
South Korea |
|
42 |
1.53 |
Feb. 3, 2025 | USD 0.50 | -4.09% |
|
South Korea |
|
43 |
1.44 |
Feb. 3, 2025 | USD 1.37 | -0.64% |
|
South Korea |
|
44 |
1.43 |
Feb. 3, 2025 | USD 1.01 | -3.22% |
|
South Korea |
|
45 |
1.42 |
Feb. 3, 2025 | USD 8.44 | -2.89% |
|
South Korea |
|
46 |
1.40 |
Feb. 3, 2025 | USD 18.22 | -3.57% |
|
South Korea |
|
47 |
1.39 |
Feb. 3, 2025 | USD 11.86 | -0.20% |
|
South Korea |
|
48 |
1.30 |
Feb. 3, 2025 | USD 8.58 | -5.12% |
|
South Korea |
|
49 |
1.23 |
Feb. 3, 2025 | USD 10.66 | -1.34% |
|
South Korea |
|
50 |
1.07 |
Feb. 3, 2025 | USD 9.81 | -0.42% |
|
South Korea |
The Healthcare company in South Korea with the highest Price to Sales Ratio (P/S) is Peptron, Inc. (KOSDAQ: 087010.KQ) at 622.22.
The Healthcare company in South Korea with the lowest Price to Sales Ratio (P/S) is iMarketKorea Inc. (KSE: 122900.KS) at 0.06.
The top 10 Healthcare companies in South Korea by Price to Sales Ratio (P/S) are Peptron, Inc., ALTEOGEN Inc., Oscotec Inc., SillaJen, Inc., Hyundai Bioscience Co., Ltd., Genexine, Inc., CrystalGenomics, Inc., Anterogen.Co.,Ltd., Helixmith Co., Ltd and ABL Bio Inc..
The bottom 10 Healthcare companies in South Korea by Price to Sales Ratio (P/S) are iMarketKorea Inc., Kwang Dong Pharmaceutical Co., Ltd., Chong Kun Dang Holdings Corp., HANDOK Inc., Green Cross Holdings Corporation, MYUNGMOON Pharm co.,Ltd, Dongwha Pharm.Co.,Ltd, Daewoong Co., Ltd., PharmGen Science, Inc. and Dong-A Socio Holdings Co., Ltd..